https://news.medxy.ai/zh/diagnostic-tools-for-peripheral-arterial-disease-in-diabetes-1/Medxy AIzh2026-07-30T16:22:21-07:00重新审视糖尿病外周动脉疾病的诊断工具：DMPAD研究带来的启示 https://news.medxy.ai/ja/diagnostic-tools-for-peripheral-arterial-disease-in-diabetes/Medxy AIja2026-07-30T16:22:06-07:00糖尿病における末梢動脈疾患の診断再考：DMPAD研究が示す臨床課題 https://news.medxy.ai/vi/reassessing-diagnostic-tools-for-peripheral-arterial-disease-in-diabetes/Medxy AIvi2026-07-30T16:21:47-07:00Đánh giá lại công cụ chẩn đoán bệnh động mạch ngoại biên ở người bệnh đái tháo đường: Phát hiện từ nghiên cứu DMPAD https://news.medxy.ai/reassessing-diagnostic-tools-for-peripheral-arterial-disease-in-diabetes-insights-from-the-dmpad-study/Medxy AIen2026-07-30T16:21:09-07:00Reassessing Diagnostic Tools for Peripheral Arterial Disease in Diabetes: Insights from the DMPAD Study https://news.medxy.ai/zh/acoramidis-improves-heart-failure-related-quality-of-life-in-transthyretin-amyloid-cardiomyopathy/Medxy AIzh2026-07-30T15:53:47-07:00Acoramidis 显著改善转甲状腺素蛋白淀粉样心肌病患者的心力衰竭相关生活质量：来自 ATTRibute-CM 试验的启示 https://news.medxy.ai/ja/acoramidis-significantly-improves-heart-failure-related-quality-of-life-in-transthyretin-amyloid-cardiomyopathy/Medxy AIja2026-07-30T15:53:31-07:00アコラミジス、ATTR-CMのQOLを有意に改善　ATTRibute-CM試験が示した心不全関連アウトカムへの効果 https://news.medxy.ai/acoramidis-significantly-improves-heart-failure-related-quality-of-life-in-transthyretin-amyloid-cardiomyopathy-insights-from-the-attribute-cm-trial/Medxy AIen2026-07-30T15:52:23-07:00Acoramidis Significantly Improves Heart Failure-Related Quality of Life in Transthyretin Amyloid Cardiomyopathy: Insights from the ATTRibute-CM Trial https://news.medxy.ai/zh/jcad-protein-for-residual-cardiovascular-risk/Medxy AIzh2026-07-30T15:42:22-07:00JCAD 蛋白：急性冠状动脉综合征残余心血管风险的新型预测因子与治疗靶点 https://news.medxy.ai/vi/jcad-protein-for-residual-cardiovascular-risk-in-acute-coronary-syndrome/Medxy AIvi2026-07-30T15:41:46-07:00JCAD: Dấu ấn sinh học và đích điều trị mới cho nguy cơ tim mạch tồn dư trong hội chứng vành cấp https://news.medxy.ai/jcad-protein-a-novel-predictor-and-therapeutic-target-for-residual-cardiovascular-risk-in-acute-coronary-syndrome/Medxy AIen2026-07-30T15:41:01-07:00JCAD Protein: A Novel Predictor and Therapeutic Target for Residual Cardiovascular Risk in Acute Coronary Syndrome https://news.medxy.ai/zh/evidence-generation-and-translation-of-anticoagulation-strategies-in-noncritically-ill-covid-19/Medxy AIzh2026-07-30T15:36:38-07:00拨开不确定性：非重症 COVID-19 患者抗凝策略的快速证据生成与转化 https://news.medxy.ai/ja/navigating-uncertainty-rapid-evidence-generation-and-translation-of-anticoagulation-strategies-in-noncritically-ill-covid-19/Medxy AIja2026-07-30T15:36:22-07:00不確実性を乗り越える：非重症COVID-19患者における抗凝固戦略の迅速なエビデンス創出と臨床応用 https://news.medxy.ai/vi/evidence-generation-and-translation-of-anticoagulation-strategies-in-noncritically-ill-covid-19-patients/Medxy AIvi2026-07-30T15:36:04-07:00Vượt qua bất định: Tạo bằng chứng nhanh và chuyển hóa chiến lược chống đông ở bệnh nhân COVID-19 nhập viện nhưng không nguy kịch https://news.medxy.ai/navigating-uncertainty-rapid-evidence-generation-and-translation-of-anticoagulation-strategies-in-noncritically-ill-covid-19-patients/Medxy AIen2026-07-30T15:35:23-07:00Navigating Uncertainty: Rapid Evidence Generation and Translation of Anticoagulation Strategies in Noncritically Ill COVID-19 Patients https://news.medxy.ai/ja/risk-guided-screening-for-atrial-fibrillation/Medxy AIja2026-07-30T15:28:57-07:00電子健康記録で心房細動を拾い上げる：リスク層別化スクリーニングの新戦略 https://news.medxy.ai/vi/screening-for-atrial-fibrillation-using-electronic-health-records/Medxy AIvi2026-07-30T15:28:40-07:00Sàng lọc rung nhĩ theo nguy cơ bằng hồ sơ sức khỏe điện tử https://news.medxy.ai/risk-guided-screening-for-atrial-fibrillation-using-electronic-health-records/Medxy AIen2026-07-30T15:28:03-07:00Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records https://news.medxy.ai/ja/survival-in-unresectable-hepatocellular-carcinoma-with-combined-transarterial-chemoembolization-and-thermal-ablation-insights-from-the-phase-3-torch-trial/Medxy AIja2026-07-30T15:18:05-07:00切除不能肝細胞癌に対する肝動脈化学塞栓療法と熱焼灼療法の併用で生存成績が改善：第3相TORCH試験の知見 https://news.medxy.ai/vi/improved-survival-in-unresectable-hepatocellular-carcinoma-with-combined-transarterial-chemoembolization-and-thermal-ablation/Medxy AIvi2026-07-30T15:17:44-07:00Kết hợp TACE và đốt nhiệt giúp cải thiện sống còn ở ung thư biểu mô tế bào gan không thể cắt bỏ: Kết quả từ thử nghiệm giai đoạn 3 TORCH https://news.medxy.ai/improved-survival-in-unresectable-hepatocellular-carcinoma-with-combined-transarterial-chemoembolization-and-thermal-ablation-insights-from-the-phase-3-torch-trial/Medxy AIen2026-07-30T15:16:53-07:00Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial https://news.medxy.ai/zh/oral-nicotinamide-for-keratinocyte-carcinoma/Medxy AIzh2026-07-30T14:42:47-07:00口服烟酰胺预防角质形成细胞癌的成本效益：临床与经济学综述 https://news.medxy.ai/ja/oral-nicotinamide-for-keratinocyte-carcinoma-prevention/Medxy AIja2026-07-30T14:42:29-07:00経口ニコチンアミドによる keratinocyte carcinoma 予防の費用対効果：臨床・経済レビュー https://news.medxy.ai/vi/cost-effectiveness-of-oral-nicotinamide-for-keratinocyte-carcinoma-prevention/Medxy AIvi2026-07-30T14:42:08-07:00Niacinamide đường uống trong dự phòng ung thư biểu mô tế bào sừng: Tổng quan lâm sàng và kinh tế https://news.medxy.ai/cost-effectiveness-of-oral-nicotinamide-for-keratinocyte-carcinoma-prevention-a-clinical-and-economic-review/Medxy AIen2026-07-30T14:41:12-07:00Cost-Effectiveness of Oral Nicotinamide for Keratinocyte Carcinoma Prevention: A Clinical and Economic Review https://news.medxy.ai/zh/diagnostic-accuracy-in-head-and-neck-pigmented-macules-the-role-of-reflectance-confocal-microscopy/Medxy AIzh2026-07-30T14:35:22-07:00头颈部色素性斑片诊断更精准：反射式共聚焦显微镜的关键价值 https://news.medxy.ai/ja/enhancing-diagnostic-accuracy-in-head-and-neck-pigmented-macules-the-role-of-reflectance-confocal-microscopy/Medxy AIja2026-07-30T14:35:05-07:00頭頸部色素性斑の診断精度を高める―反射型共焦点顕微鏡の重要性 https://news.medxy.ai/vi/diagnostic-accuracy-in-head-and-neck-pigmented-macules-the-critical-role-of-reflectance-confocal-microscopy/Medxy AIvi2026-07-30T14:34:48-07:00Nâng cao độ chính xác chẩn đoán các dát sắc tố ở vùng đầu và cổ: Vai trò quyết định của kính hiển vi đồng tiêu phản xạ https://news.medxy.ai/enhancing-diagnostic-accuracy-in-head-and-neck-pigmented-macules-the-critical-role-of-reflectance-confocal-microscopy/Medxy AIen2026-07-30T14:34:02-07:00Enhancing Diagnostic Accuracy in Head and Neck Pigmented Macules: The Critical Role of Reflectance Confocal Microscopy https://news.medxy.ai/zh/impact-of-preoperative-serotonergic-antidepressants-on-rhinoplasty-outcomes/Medxy AIzh2026-07-30T14:33:08-07:00术前5-羟色胺能抗抑郁药对鼻整形术后结局的影响：一项倾向评分匹配研究 https://news.medxy.ai/ja/preoperative-serotonergic-antidepressants-on-post-rhinoplasty-outcomes/Medxy AIja2026-07-30T14:32:53-07:00鼻形成術後転帰に対する術前セロトニン作動性抗うつ薬の影響：傾向スコアマッチング研究 https://news.medxy.ai/vi/impact-of-preoperative-serotonergic-antidepressants-on-post-rhinoplasty-outcomes/Medxy AIvi2026-07-30T14:32:37-07:00Ảnh hưởng của thuốc chống trầm cảm serotonergic trước phẫu thuật lên kết cục sau phẫu thuật tạo hình mũi: Nghiên cứu ghép cặp theo điểm xu hướng https://news.medxy.ai/impact-of-preoperative-serotonergic-antidepressants-on-post-rhinoplasty-outcomes-a-propensity-score-matched-study/Medxy AIen2026-07-30T14:31:55-07:00Impact of Preoperative Serotonergic Antidepressants on Post-Rhinoplasty Outcomes: A Propensity Score-Matched Study https://news.medxy.ai/ja/impact-of-timing-of-hard-palate-closure-on-maxillary-growth-in-cleft-lip-alveolus-and-palate-patients/Medxy AIja2026-07-30T14:24:02-07:00硬口蓋閉鎖の時期は上顎成長にどう影響するか：唇顎口蓋裂患者に関する包括的レビュー https://news.medxy.ai/impact-of-timing-of-hard-palate-closure-on-maxillary-growth-in-cleft-lip-alveolus-and-palate-patients-a-comprehensive-review/Medxy AIen2026-07-30T14:22:35-07:00Impact of Timing of Hard Palate Closure on Maxillary Growth in Cleft Lip, Alveolus, and Palate Patients: A Comprehensive Review https://news.medxy.ai/ja/adolescent-peer-on-mental-disorder-risk-diagnoses-and-genetic-predispositions/Medxy AIja2026-07-30T14:21:07-07:00青少年の同輩影響が精神障害リスクに与える作用：集団コホートにおける診断と遺伝的素因 https://news.medxy.ai/vi/adolescent-peer-influences-on-mental-disorder-risk-diagnoses-and-genetic-predispositions/Medxy AIvi2026-07-30T14:20:48-07:00青少年同伴影响如何塑造精神障碍风险：基于人群队列的诊断与遗传易感性研究 https://news.medxy.ai/adolescent-peer-influences-on-mental-disorder-risk-diagnoses-and-genetic-predispositions-in-population-cohorts/Medxy AIen2026-07-30T14:19:51-07:00Adolescent Peer Influences on Mental Disorder Risk: Diagnoses and Genetic Predispositions in Population Cohorts https://news.medxy.ai/ja/stardaki-standardizing-acute-kidney-injury/Medxy AIja2026-07-30T14:11:25-07:00STARDaki：急性腎障害バイオマーカー研究の報告を標準化する https://news.medxy.ai/vi/stardaki-standardizing-acute-kidney-injury-biomarker/Medxy AIvi2026-07-30T14:10:56-07:00STARDaki: Chuẩn hóa cách báo cáo các nghiên cứu dấu ấn sinh học tổn thương thận cấp https://news.medxy.ai/zh/stardaki-standardizing-acute-kidney-injury-biomarker-studies/Medxy AIzh2026-07-30T14:10:27-07:00STARDaki：规范急性肾损伤生物标志物研究报告的新共识 https://news.medxy.ai/stardaki-standardizing-how-we-report-acute-kidney-injury-biomarker-studies/Medxy AIen2026-07-30T14:07:50-07:00STARDaki: Standardizing How We Report Acute Kidney Injury Biomarker Studies